https://clinicaltrials.gov/ct2/show/NCT02550652?type=Intr&cond=Lupus&phase=012345&lupd_s=03%2F15%2F2019&lupd_d=14
Condition : Lupus Nephritis
Interventions : Drug: Mycophenolate Mofetil/Mycophenolic Acid; Drug: Obinutuzumab; Other: Placebo; Drug: Methylprednisolone; Drug: Prednisone
Sponsor : Hoffmann-La Roche
Active, not recruiting
A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)
NCT02550652
Tue, 15 Sep 2015 12:00:00 EDT
